A closer look at severe tricuspid regurgitation in AFMR patients
Peer-Reviewed Publication
In recognition of Heart Health Month, we’re spotlighting the importance of cardiovascular wellness. From risk factors and prevention to innovative treatments, we’re exploring the science and stories shaping heart health today.
Updates every hour. Last Updated: 8-Sep-2025 14:11 ET (8-Sep-2025 18:11 GMT/UTC)
Tricuspid regurgitation (TR) is common in patients with atrial functional mitral regurgitation (AFMR) but its impact is not well understood. Japanese researchers have now examined severe TR in AFMR patients, revealing it affects one in seven to eight patients and significantly raises the risk of death or heart failure-related hospitalization by 1.65 times (95% confidence interval 1.09–2.47). These findings highlight the importance of monitoring TR severity to improve outcomes for AFMR patients.
New American Heart Association scientific statement: Peripheral vascular disease (PVD)—a condition affecting arteries, veins and the lymphatic systems throughout the body—has significant differences in incidence, risk factors, diagnosis, treatment and outcomes in women vs. men.
Kayunta Johnson-Winters, an associate professor of chemistry and biochemistry at The University of Texas at Arlington, has been named a 2025 fellow of the American Society for Biochemistry and Molecular Biology. The honor recognition recognizes her contributions to biochemistry and molecular biology and her efforts to support junior faculty, women in science and student mentorship.